MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

Por Slaby, Ondrej, Svoboda, Marek, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2009

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer

Por Slaby, Ondrej, Bienertova-Vasku, Julie, Svoboda, Marek, Vyzula, Rostislav
Publicado em 2012

MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications

Por Sana, Jiri, Hajduch, Marian, Michalek, Jaroslav, Vyzula, Rostislav, Slaby, Ondrej
Publicado no J Cell Mol Med (2011)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

Por Svoboda Marek, Sana Jiri, Redova Martina, Navratil Jiri, Palacova Marketa, Fabian Pavel, Slaby Ondrej, Vyzula Rostislav
Publicado em 2012-03-01

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

Por Svoboda, Marek, Sana, Jiri, Redova, Martina, Navratil, Jiri, Palacova, Marketa, Fabian, Pavel, Slaby, Ondrej, Vyzula, Rostislav
Publicado em 2012

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previou...

Por Brozkova, Kristyna, Budinska, Eva, Bouchal, Pavel, Hernychova, Lenka, Knoflickova, Dana, Valik, Dalibor, Vyzula, Rostislav, Vojtesek, Borivoj, Nenutil, Rudolf
Publicado em 2008

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Por Slaby, Ondrej, Jancovicova, Jana, Lakomy, Radek, Svoboda, Marek, Poprach, Alexandr, Fabian, Pavel, Kren, Leos, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2010

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Por Slaby, Ondrej, Jancovicova, Jana, Lakomy, Radek, Svoboda, Marek, Poprach, Alexandr, Fabian, Pavel, Kren, Leos, Michalek, Jaroslav, Vyzula, Rostislav
Publicado em 2010

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry

Por Pavlík, Tomáš, Májek, Ondřej, Mužík, Jan, Koptíková, Jana, Slavíček, Lubomír, Fínek, Jindřich, Feltl, David, Vyzula, Rostislav, Dušek, Ladislav
Publicado em 2012

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

Por Redova, Martina, Poprach, Alexandr, Nekvindova, Jana, Iliev, Robert, Radova, Lenka, Lakomy, Radek, Svoboda, Marek, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

Por Svoboda, Marek, Sana, Jiri, Fabian, Pavel, Kocakova, Ilona, Gombosova, Jana, Nekvindova, Jana, Radova, Lenka, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

Por GRELL, PETER, FABIAN, PAVEL, KHOYLOU, MARTA, RADOVA, LENKA, SLABY, ONDREJ, HRSTKA, ROMAN, VYZULA, ROSTISLAV, HAJDUCH, MARIAN, SVOBODA, MAREK
Publicado em 2012

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib

Por Merhautova, Jana, Hezova, Renata, Poprach, Alexandr, Kovarikova, Alena, Radova, Lenka, Svoboda, Marek, Vyzula, Rostislav, Demlova, Regina, Slaby, Ondrej
Publicado no Biomed Res Int (2015)

Common polymorphisms in <it>GSTM1, GSTT1, GSTP1, GSTA1</it> and susceptibility to colorectal cancer in the Central European population

Por Hezova Renata, Bienertova-Vasku Julie, Sachlova Milana, Brezkova Veronika, Vasku Anna, Svoboda Marek, Radová Lenka, Kiss Igor, Vyzula Rostislav, Slaby Ondrej
Publicado em 2012-06-01

Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population

Por Hezova, Renata, Bienertova-Vasku, Julie, Sachlova, Milana, Brezkova, Veronika, Vasku, Anna, Svoboda, Marek, Radová, Lenka, Kiss, Igor, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

Por Slavicek, Lubomir, Pavlik, Tomas, Tomasek, Jiri, Bortlicek, Zbynek, Buchler, Tomas, Melichar, Bohuslav, Vyzula, Rostislav, Prausova, Jana, Finek, Jindrich, Majek, Ondrej, Dusek, Ladislav
Publicado em 2014

Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer

Por Hezova, Renata, Kovarikova, Alena, Bienertova-Vasku, Julie, Sachlova, Milana, Redova, Martina, Vasku, Anna, Svoboda, Marek, Radova, Lenka, Kiss, Igor, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view

Por Bencsikova, Beatrix, Bortlicek, Zbynek, Halamkova, Jana, Ostrizkova, Lenka, Kiss, Igor, Melichar, Bohuslav, Pavlik, Tomas, Dusek, Ladislav, Valik, Dalibor, Vyzula, Rostislav, Zdrazilova-Dubska, Lenka
Publicado no BMC Gastroenterol (2015)

Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-b...

Por Buchler, Tomas, Pavlik, Tomas, Melichar, Bohuslav, Bortlicek, Zbynek, Usiakova, Zuzana, Dusek, Ladislav, Kiss, Igor, Kohoutek, Milan, Benesova, Vera, Vyzula, Rostislav, Abrahamova, Jitka, Obermannova, Radka
Publicado em 2014

Identification and functional screening of microRNAs highly deregulated in colorectal cancer

Por Faltejskova, Petra, Svoboda, Marek, Srutova, Klara, Mlcochova, Jitka, Besse, Andrej, Nekvindova, Jana, Radova, Lenka, Fabian, Pavel, Slaba, Katerina, Kiss, Igor, Vyzula, Rostislav, Slaby, Ondrej
Publicado em 2012